MarketInOut Stock Screener Log In | Sign Up
 

Haemonetics Corp

NYSE • Healthcare • Medical Devices • Quote as of 08/13/2026 11:53
Haemonetics Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization3,968.25 mln
Float43.96 mln
Earnings Date11/05/2026

EPS

2.08
Stretched

P / E

43.97
High premium

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.71
Likely reliable

1-Year Forecast

96.20
Modest upside

Relative Strength

83 / 100
Strongly outperforming

Business Description

Haemonetics is a Boston-based medical technology company founded in 1971 that operates across the United States and in markets worldwide. The company makes equipment, software, and disposable products that support blood and plasma collection, surgical procedures, and patient monitoring in hospital settings. Its offerings help healthcare providers manage donor operations, guide complex cardiac interventions, assess blood clotting, and recover a patient's own blood during surgery. Haemonetics reaches its customers through a combination of direct sales staff, independent distributors, and clinical specialists.

Key Fundamentals

EPS2.08
P/E43.97
ROE11.26
RPS28.97
ROIC8.84
ROA3.96
Interest Cover8.20
EBITDA, mln270
EV / EBITDA18.30
EV / EBIT30.86
Revenue, mln1,352
EV / Revenue3.66

Financial Strength

Altman Z-Score2.78
Piotroski F-Score 7 / 9
Beneish M-Score-2.71
Price to Lynch Fair Value1.03
1-Year Target Price96.20
Shiller PE Ratio47.40
Short Ratio4.59
Short % of Float7.51

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.55% 93 / 100   
1 Month 19.25% 95 / 100   
2 Months 73.61% 99 / 100   
6 Months 59.03% 97 / 100   
1 Year 75.07% 94 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us